Perspectives in AML treatment: targeting apoptosis without chemotherapy by using BH3-mimetics
Treatment landscape for elderly acute myeloid leukemia (AML) patients
CheckMate study and the role of nivolumab in Hodgkin lymphoma
Is autologous stem cell transplantation still the backbone of multiple myeloma treatment?
What is the potential of daratumumab in combination therapy for myeloma?